陆军军医大学(第三军医大学)第一附属医院麻醉科,围手术期多器官保护与智慧麻醉重点实验室,重庆
YI Bin, E-mail: yibin1974@tmmu.edu.cn
Received:24 December 2025,
Revised:2026-01-22,
Published:30 March 2026
移动端阅览
孙静,李雨捷,刘祥,等.右美托咪定可缩短ICU机械通气患者拔管时间:一项回顾性队列研究[J].陆军军医大学学报,2026,48(06):768-782.DOI:10.16016/j.2097-0927.202512139.
SUN J,LI Y J,LIU X,et al.Dexmedetomidine shortens time to extubation in mechanically ventilated ICU patients: A retrospective cohort study[J].J Army Med Univ,2026,48(06):768-782.DOI:10.16016/j.2097-0927.202512139.
孙静,李雨捷,刘祥,等.右美托咪定可缩短ICU机械通气患者拔管时间:一项回顾性队列研究[J].陆军军医大学学报,2026,48(06):768-782.DOI:10.16016/j.2097-0927.202512139. DOI:
SUN J,LI Y J,LIU X,et al.Dexmedetomidine shortens time to extubation in mechanically ventilated ICU patients: A retrospective cohort study[J].J Army Med Univ,2026,48(06):768-782.DOI:10.16016/j.2097-0927.202512139. DOI:
目的
2
探讨不同镇静策略对接受有创机械通气(invasive mechanical ventilation,IMV)的重症监护病房(ICU)患者短期预后的影响, 同时评估在高龄、合并恶性肿瘤或肝功能受损等特殊人群中是否存在差异。
方法
2
本研究为回顾性观察性队列研究,数据来源于MIMIC-IV(v2.2)与eICU-CRD(v2.0)两大重症数据库。纳入标准:年龄≥18岁;入ICU后48 h内接受气管插管并行有创机械通气;ICU住院时长≥48 h;气管插管前2 h至插管后48 h内启动单一镇静策略(右美托咪定、丙泊酚、苯二氮䓬类药物)。排除联合镇静策略、再插管及单药样本量<100例者。主要结局为拔管时间;次要结局包括院内死亡率、ICU住院时间、谵妄发生率及心血管不良事件发生率。基于梯度提升机算法的倾向评分进行逆概率加权(IPTW)控制混杂偏倚,随后利用增强逆概率加权(AIPW)双重稳健模型估计平均处理效应(ATE)、OR及95%CI;预设亚组分析检验年龄、恶性肿瘤及肝病状态的交互作用。
结果
2
本研究最终共纳入12 561名患者,其中右美托咪定组1 111例,丙泊酚组8 021例,苯二氮䓬类组3 429例。IPTW加权后,各基线变量总体达到平衡。在AIPW双重稳健模型中,与右美托咪定组相比,丙泊酚组拔管时间延长0.782 d(ATE=0.782 d,95%
CI
:0.769~0.796,
P
<
0.001),苯二氮䓬类组延长1.791 d(ATE=1.791 d,95%
CI
:1.779~1.804,
P
<
0.001);与苯二氮䓬类相比,丙泊酚组拔管时间缩短1.009 d(ATE=-1.009 d,95%
CI
:-1.018~-1.000,
P
<
0.001)。次要结局:与右美托咪定相比,丙泊酚与苯二氮䓬类
院内死亡风险升高(丙泊酚:
OR
=1.905,95%
CI
:1.647~2.201,
P
<
0.001;苯二氮䓬类:
OR
=2.768,95%
CI
:2.262~3.388,
P
<
0.001),谵妄风险亦升高(丙泊酚:
OR
=1.905,95%
CI
:1.428~2.541,
P
<
0.001;苯二氮䓬类:
OR
=2.382,95%
CI
:1.681~3.376,
P
<
0.001)。此外,ICU住院时间在丙泊酚组与苯二氮䓬类组分别延长0.367 d与1.012 d(丙泊酚:ATE=0.367 d,95%
CI
:0.351~0.382,
P
<
0.001;苯二氮䓬类:ATE=1.012 d,95%
CI
:0.996~1.029,
P
<
0.001),总心血管不良事件次数分别增加6.527次与15.199次(丙泊酚:ATE=6.527次,95%
CI
:6.112~6.942,
P
<
0.001;苯二氮䓬类:ATE=15.199次,95%
CI
:14.727~15.671,
P
<
0.001)。呼吸机相关肺炎(VAP)方面,丙泊酚相较右美托咪定风险更低(
OR
=0.722,95%
CI
:0.648~0.805,
P
<
0.001),苯二氮䓬类与右美托咪定差异不显著(
OR
=1.082,95%
CI
:0.934~1.252,
P
=1.000)。亚组与交互作用分析显示,镇静策略与恶性肿瘤(
P
-for-interaction=0.001)及中重度肝病(
P
-for-interaction=0.048)存在显著交互:在合并恶性肿瘤患者中,丙泊酚组较右美托咪定组拔管时间呈缩短趋势(ATE=-1.326 d,95%
CI
:-2.732~0.080,
P
=0.064);在中重度肝病患者中,丙泊酚组较右美托咪定组拔管时间亦呈缩短趋势(ATE=-1.232 d,95%
CI
:-2.939~0.475,
P
=0.157),提示上述特殊人群中右美托咪定的获益减弱甚至可能发生方向改变。
结论
2
对于ICU有创机械通气患者,右美托咪定相较丙泊酚与苯二氮䓬类与更短拔管时间及更低院内死亡率、谵妄与心血管不良事件风险相关;但在合并恶性肿瘤或中重度肝病患者中,右美托咪定的优势减弱。
Objective
2
To investigate the impact of different sedation strategies on short-term outcomes in intensive care unit (ICU) patients receiving invasive mechanical ventilation (IMV)
and to assess whether these effects differ in special populations such as the elderly
those with malignancy
or hepatic impairment.
Methods
2
This retrospective observational cohort study utilized data from 2 large critical care databases
MIMIC-IV (v2.2) and eICU-CRD (v2.0). Inclusion criteria were: age ≥18 years; endotracheal intubation and IMV within 48 h after ICU admission; ICU length of stay (LOS) ≥48 h; initiation of a single-agent sedation strategy (dexmedetomidine
propofol
or benzodiazepines) from 2 h before to 48 h after intubation. Patients receiving combined sedatives
undergoing re-intubation
or with single-drug sample sizes <100 were excluded. The primary outcome was time to extubation; secondary outcomes included in-hospital mortality
ICU LOS
incidence of delirium
and major adverse cardiovascular events (MACEs). Inverse probability of treatment weighting (IPTW) based on gradient boosting machine algorithms was employed to control confounding bias
followed by augmented inverse probability weighting (AIPW) doubly robust models to estimate average treatment effects (ATE)
odds ratios (ORs)
and 95% confidence intervals (CIs). Prespecified subgroup analyses were applied to examine interactions with age
malignancy
and hepatic status.
Results
2
A total of 12 561 patients were enrolled
comprising 1 111 in the dexmedetomidine group
8 021 in the propofol group
and 3 429 in the benzodiazepine group. After IPTW weighting
baseline variables achieved overall balance across groups. In the AIPW doubly robust models
compared with the dexmedetomidine group
the propofol group demonstrated prolonged time to extubation by 0.782 d (
ATE
=0.782 d
95%
CI
: 0.769 to 0.796
P
<
0.001)
and the benzodiazepine group by 1.791 d (
ATE
=1.791 d
95%
CI
: 1.779 to 1.804
P
<
0.001); compared with benzodiazepines
the propofol group showed shortened extubation time by 1.009 d (
ATE
=-1.009 d
95%
CI
: -1.018 to -1.000
P
<
0.001). For secondary outcomes
compared with dexmedetomidine
both propofol and benzodiazepines were associated with increased risk for in-hospital mortal
ity (propofol:
OR
=1.905
95%
CI
: 1.647 to 2.201
P
<
0.001; benzodiazepines:
OR
=2.768
95%
CI
: 2.262 to 3.388
P
<
0.001) and for delirium (propofol:
OR
=1.905
95%
CI
: 1.428 to 2.541
P
<
0.001; benzodiazepines:
OR
=2.382
95%
CI
: 1.681 to 3.376
P
<
0.001). Additionally
ICU LOS was prolonged by 0.367 d and 1.012 d in the propofol and benzodiazepine groups
respectively (propofol: ATE=0.367 d
95%
CI
: 0.351 to 0.382
P
<
0.001; benzodiazepines: ATE=1.012 d
95%
CI
: 0.996 to 1.029
P
<
0.001)
and the total incidence of MACEs increased by 6.527 and 15.199 events (propofol: ATE=6.527 events
95%
CI
: 6.112 to 6.942
P
<
0.001; benzodiazepines: ATE=15.199 events
95%
CI
: 14.727 to 15.671
P
<
0.001). Regarding ventilator-associated pneumonia (VAP)
propofol was associated with a lower risk than dexmedetomidine (
OR
=0.722
95%
CI
: 0.648 to 0.805
P
<
0.001)
whereas no significant difference was observed between benzodiazepines and dexmedetomidine (
OR
=1.082
95%
CI
: 0.934~1.252
P
=1.000). Subgroup and interaction analyses revealed significant interactions between sedation strategy and malignancy (
P
-for-interaction=0.001) and moderate-to-severe liver disease (
P
-for-interaction=0.048). Among patients with malignancy
propofol showed a trend toward shorter time to extubation than dexmedetomidine (ATE=-1.326 d
95%
CI
: -2.732 to -0.080
P
=0.064); similarly
in patients with moderate-to-severe liver disease
propofol also demonstrated a trend toward shorter extubation time than dexmedetomidine (ATE=-1.232 d
95%
CI
: -2.939 to
-0.475
P
=0.157)
suggesting attenuated or even reversed benefits of dexmedetomidine in these special populations.
Conclusion
2
In ICU patients receiving invasive mechanical ventilation
dexmedetomidine
is associated with shorter time to extubation and lower risks of in-hospital mortality
delirium
and cardiovascular adverse events compared with propofol and benzodiazepines. However
these advantage of dexmedetomidine are diminished among patients with malignancy or moderate-to-severe liver disease.
LIU R H , SU B X , GAN G F , et al . Effect of remimazolam besylate versus midazolam on time to extubation in critically ill, mechanically ventilated patients: a randomized controlled trial [J]. Front Med , 2025 , 12 : 1553495 . DOI: 10.3389/fmed.2025.1553495 http://dx.doi.org/10.3389/fmed.2025.1553495 .
TASHIRO N , NISHIWAKI H , IKEDA T , et al . Clinical utility of diaphragmatic ultrasound for mechanical ventilator liberation in adults: a systematic review and meta-analysis [J]. J Intensive Care , 2025 , 13 ( 1 ): 40 . DOI: 10.1186/s40560-025-00811-0 http://dx.doi.org/10.1186/s40560-025-00811-0 .
HUME N E , ZERFAS I , WONG A , et al . Clinical impact of the implementation strategies used to apply the 2013 pain, agitation/sedation, delirium or 2018 pain, agitation/sedation, delirium, immobility, sleep disruption guideline recommendations: a systematic review and meta-analysis [J]. Crit Care Med , 2024 , 52 ( 4 ): 626 - 636 . DOI: 10.1097/CCM.0000000000006178 http://dx.doi.org/10.1097/CCM.0000000000006178 .
MADKHALI M M , ALFAIFI M M , SAFHI A Y , et al . The role of anesthesia in sedation and weaning from mechanical ventilation: a systematic review [J]. Cureus , 2025 , 17 ( 4 ): e82074 . DOI: 10.7759/cureus.82074 http://dx.doi.org/10.7759/cureus.82074 .
MAAGAARD M , BARBATESKOVIC M , ANDERSEN-RANBERG N C , et al . Dexmedetomidine for the prevention of delirium in adults admitted to the intensive care unit or post-operative care unit: a systematic review of randomised clinical trials with meta-analysis and Trial Sequential Analysis [J]. Acta Anaesthesiol Scand , 2023 , 67 ( 4 ): 382 - 411 . DOI: 10.1111/aas.14208 http://dx.doi.org/10.1111/aas.14208 .
TURUNEN H , JAKOB S M , RUOKONEN E , et al . Dexmedetomidine versus standard care sedation with propofol or midazolam in intensive care: an economic evaluation [J]. Crit Care , 2015 , 19 ( 1 ): 67 . DOI: 10.1186/s13054-015-0787-y http://dx.doi.org/10.1186/s13054-015-0787-y .
CRUICKSHANK M , HENDERSON L , MACLENNAN G , et al . Alpha-2 agonists for sedation of mechanically ventilated adults in intensive care units: a systematic review [J]. Health Technol Assess , 2016 , 20 ( 25 ): v-xx, 1 - 117 . DOI: 10.3310/hta20250 http://dx.doi.org/10.3310/hta20250 .
PAN H , LIU C X , MA X C , et al . Perioperative dexmedetomidine reduces delirium in elderly patients after non-cardiac surgery: a systematic review and meta-analysis of randomized-controlled trials [J]. Can J Anaesth , 2019 , 66 ( 12 ): 1489 - 1500 . DOI: 10.1007/s12630-019-01440-6 http://dx.doi.org/10.1007/s12630-019-01440-6 .
WALSH T S , PARKER R A , AITKEN L M , et al . Dexmedetomidine- or clonidine-based sedation compared with propofol in critically ill patients: the A2B randomized clinical trial [J]. JAMA , 2025 , 334 ( 1 ): 32 - 45 . DOI: 10.1001/jama.2025.7200 http://dx.doi.org/10.1001/jama.2025.7200 .
MEHTANI R , GARG S , KAJAL K , et al . Neurological monitoring and sedation protocols in the Liver Intensive Care Unit [J]. Metab Brain Dis , 2022 , 37 ( 5 ): 1291 - 1307 . DOI: 10.1007/s11011-022-00986-7 http://dx.doi.org/10.1007/s11011-022-00986-7 .
CERIC A , HOLGERSSON J , MAY T L , et al . Effect of level of sedation on outcomes in critically ill adult patients: a systematic review of clinical trials with meta-analysis and trial sequential analysis [J]. EClinicalMedicine , 2024 , 71 : 102569 . DOI: 10.1016/j.eclinm.2024.102569 http://dx.doi.org/10.1016/j.eclinm.2024.102569 .
KEADY T , NARAYANAN M . Sedation and neuromuscular blockade in oncology critical care [M]// Onco-critical Care . Singapore : Springer Nature Singapore , 2022 : 73 - 83 . DOI: 10.1007/978-981-16-9929-0_8 http://dx.doi.org/10.1007/978-981-16-9929-0_8 .
LEWIS K , BALAS M C , STOLLINGS J L , et al . Executive summary of a focused update to the clinical practice guidelines for the prevention and management of pain, anxiety, agitation/sedation, delirium, immobility, and sleep disruption in adult patients in the ICU [J]. Crit Care Med , 2025 , 53 ( 3 ): e701 - e710 . DOI: 10.1097/CCM.000000000000 6573 http://dx.doi.org/10.1097/CCM.0000000000006573 .
JOHNSON A , BULGARELLI L , POLLARD T , et al . MIMIC-IV Clinical Database Demo (version 2.2) [DB]. PhysioNet , 2023 . https://doi.org/10.13026/6mm1-ek67 https://doi.org/10.13026/6mm1-ek67
JOHNSON A E W , BULGARELLI L , SHEN L , et al . MIMIC-IV, a freely accessible electronic health record dataset [J]. Sci Data , 2023 , 10 ( 1 ): 1 . DOI: 10.1038/s41597-022-01899-x http://dx.doi.org/10.1038/s41597-022-01899-x .
JOHNSON A , POLLARD T , BADAWI O , et al . eICU Collaborative Research Database Demo (version 2.0 .1) [DB]. PhysioNet , 2021 . https://doi.org/10.13026/6m1f-6e97 https://doi.org/10.13026/6m1f-6e97
LIU J , ZHOU Y , HUANG H Z , et al . Impact of stress hyperglycemia ratio on mortality in patients with critical acute myocardial infarction: insight from American MIMIC-IV and the Chinese CIN-II study [J]. Cardiovasc Diabetol , 2023 , 22 ( 1 ): 281 . DOI: 10.1186/s12933-023-02012-1 http://dx.doi.org/10.1186/s12933-023-02012-1 .
Chen Y , Jiang H , Wei Y , et al . Blood pressure response index and clinical outcomes in patients with septic shock: a multicenter cohort study [J]. EBioMedicine , 2024 , 106 : 105257 . DOI: 10.1016/j.ebiom.2024.105257 http://dx.doi.org/10.1016/j.ebiom.2024.105257 .
SLEE A , NAZARETH I , BONDARONEK P , et al . Pharmacological treatments for generalised anxiety disorder: a systematic review and network meta-analysis [J]. Lancet , 2019 , 393 ( 10173 ): 768 - 777 . DOI: 10.1016/S0140-6736(18)31793-8 http://dx.doi.org/10.1016/S0140-6736(18)31793-8 .
VAN BUUREN S , GROOTHUIS-OUDSHOORN K . mice : multivariate imputation by chained equations in R [J]. J Stat Soft , 2011 , 45 ( 3 ): 1 - 67 . DOI: 10.18637/jss.v045.i03 http://dx.doi.org/10.18637/jss.v045.i03 .[LinkOut]
EARLA J R , LI J N , HUTTON G J , et al . Comparative adherence trajectories of oral disease-modifying agents in multiple sclerosis [J]. Pharmacotherapy , 2023 , 43 ( 6 ): 473 - 484 . DOI: 10.1002/phar.2810 http://dx.doi.org/10.1002/phar.2810 .
CHEN C B , GUAN H T , SHEN S Y , et al . Drug-coated balloon with bailout stenting versus drug-eluting stent plus drug-coated balloon in TransAtlantic Inter-Society Consensus C and D femoropopliteal lesions: a propensity score-matched analysis [J]. Quant Imaging Med Surg , 2025 , 15 ( 9 ): 7727 - 7737 . DOI: 10.21037/qims-2025-367 http://dx.doi.org/10.21037/qims-2025-367 .
PADALINO M A , CONSTANTINE A , BERGONZONI E , et al . Early outcomes of children with univentricular circulation undergoing Fontan surgery: the EuroFontan registry [J]. Eur Heart J , 2026 , 47 ( 7 ): 842 - 850 . DOI: 10.1093/eurheartj/ehaf835 http://dx.doi.org/10.1093/eurheartj/ehaf835 .
GOLIGHER E C , DRES M , FAN E , et al . Mechanical ventilation-induced diaphragm atrophy strongly impacts clinical outcomes [J]. Am J Respir Crit Care Med , 2018 , 197 ( 2 ): 204 - 213 . DOI: 10.1164/rccm.201703-0536OC http://dx.doi.org/10.1164/rccm.201703-0536OC .
PAUL N , RIBET BUSE E , GRUNOW J J , et al . Prolonged mechanical ventilation in critically ill patients: six-month mortality, care pathways, and quality of life [J]. Chest , 2025 , 168 ( 1 ): 106 - 118 . DOI: 10.1016/j.chest.2025.01.018 http://dx.doi.org/10.1016/j.chest.2025.01.018 .
HEYBATI K , ZHOU F W , ALI S , et al . Outcomes of dexmedetomidine versus propofol sedation in critically ill adults requiring mechanical ventilation: a systematic review and meta-analysis of randomised controlled trials [J]. Br J Anaesth , 2022 , 129 ( 4 ): 515 - 526 . DOI: 10.1016/j.bja. 2022. 06.020 http://dx.doi.org/10.1016/j.bja.2022.06.020 .
LEWIS K , BALAS M C , STOLLINGS J L , et al . A focused update to the clinical practice guidelines for the prevention and management of pain, anxiety, agitation/sedation, delirium, immobility, and sleep disruption in adult patients in the ICU [J]. Crit Care Med , 2025 , 53 ( 3 ): e711 - e727 . DOI: 10.1097/CCM.0000000000006574 http://dx.doi.org/10.1097/CCM.0000000000006574 .
KEATING G M . Dexmedetomidine: a review of its use for sedation in the intensive care setting [J]. Drugs , 2015 , 75 ( 10 ): 1119 - 1130 . DOI: 10.1007/s40265-015-0419-5 http://dx.doi.org/10.1007/s40265-015-0419-5 .
PEREIRA J V , SANJANWALA R M , MOHAMMED M K , et al . Dexmedetomidine versus propofol sedation in reducing delirium among older adults in the ICU: a systematic review and meta-analysis [J]. Eur J Anaesthesiol , 2020 , 37 ( 2 ): 121 - 131 . DOI: 10.1097/EJA.0000000000001131 http://dx.doi.org/10.1097/EJA.0000000000001131 .
NGUYEN J , NACPIL N . Effectiveness of dexmedetomidine versus propofol on extubation times, length of stay and mortality rates in adult cardiac surgery patients: a systematic review and meta-analysis [J]. JBI Database System Rev Implement Rep , 2018 , 16 ( 5 ): 1220 - 1239 . DOI: 10.11124/JBISRIR-2017-003488 http://dx.doi.org/10.11124/JBISRIR-2017-003488 .
SHEHABI Y , HOWE B D , BELLOMO R , et al . Early sedation with dexmedetomidine in critically ill patients [J]. N Engl J Med , 2019 , 380 ( 26 ): 2506 - 2517 . DOI: 10.1056/NEJMoa1904710 http://dx.doi.org/10.1056/NEJMoa1904710 .
DUAN X , COBURN M , ROSSAINT R , et al . Efficacy of perioperative dexmedetomidine on postoperative delirium: systematic review and meta-analysis with trial sequential analysis of randomised controlled trials [J]. Br J Anaesth , 2018 , 121 ( 2 ): 384 - 397 . DOI: 10.1016/j.bja.2018.04.046 http://dx.doi.org/10.1016/j.bja.2018.04.046 .
READE M C , FINFER S . Sedation and delirium in the intensive care unit [J]. N Engl J Med , 2014 , 370 ( 5 ): 444 - 454 . DOI: 10.1056/NEJMra1208705 http://dx.doi.org/10.1056/NEJMra1208705 .
PENOVICH P E , RAO V R , LONG L , et al . Benzodiazepines for the Treatment of Seizure Clusters [J]. CNS Drugs , 2024 , 38 ( 2 ): 125 - 140 . DOI: 10.1007/s40263-023-01060-1 http://dx.doi.org/10.1007/s40263-023-01060-1 .
DEVLIN J W , SKROBIK Y , GÉLINAS C , et al . Clinical practice guidelines for the prevention and management of pain, agitation/sedation, delirium, immobility, and sleep disruption in adult patients in the ICU [J]. Crit Care Med , 2018 , 46 ( 9 ): e825 - e873 . DOI: 10.1097/CCM. 000000000000 3299 http://dx.doi.org/10.1097/CCM.0000000000003299 .
OLSEN H T , NEDERGAARD H K , STRØM T , et al . Nonsedation or light sedation in critically ill, mechanically ventilated patients [J]. N Engl J Med , 2020 , 382 ( 12 ): 1103 - 1111 . DOI: 10.1056/NEJMoa1906759 http://dx.doi.org/10.1056/NEJMoa1906759 .
KLOMPAS M . Ventilator-associated events: what they are and what they are not [J]. Respir Care , 2019 , 64 ( 8 ): 953 - 961 . DOI: 10.4187/respcare.07059 http://dx.doi.org/10.4187/respcare.07059 .
CHANQUES G , CONSTANTIN J M , DEVLIN J W , et al . Analgesia and sedation in patients with ARDS [J]. Intensive Care Med , 2020 , 46 ( 12 ): 2342 - 2356 . DOI: 10.1007/s00134-020-06307-9 http://dx.doi.org/10.1007/s00134-020-06307-9 .
MEHTA S , SPIES C , SHEHABI Y . Ten tips for ICU sedation [J]. Intensive Care Med , 2018 , 44 ( 7 ): 1141 - 1143 . DOI: 10.1007/s00134-017-4992-9 http://dx.doi.org/10.1007/s00134-017-4992-9 .
STERR F , REINTKE M , BAUERNFEIND L , et al . Predictors of weaning failure in ventilated intensive care patients: a systematic evidence map [J]. Crit Care , 2024 , 28 ( 1 ): 366 . DOI: 10.1186/s13054-024-05135-3 http://dx.doi.org/10.1186/s13054-024-05135-3 .
LI Y W , WU Y , LI R L , et al . Propofol regulates the surface expression of GABAA receptors: implications in synaptic inhibition [J]. Anesth Analg , 2015 , 121 ( 5 ): 1176 - 1183 . DOI: 10.1213/ANE.0000000000000884 http://dx.doi.org/10.1213/ANE.0000000000000884 .
PATEL A , GARG R , BHARTI S J , et al . Comparison of sedation efficacy of intravenous infusion of dexmedetomidine versus propofol in terms of opioid consumption in patients requiring postoperative mechanical ventilation after head and neck onco-surgeries—A randomized prospective study [J]. Indian J Cancer , 2024 , 61 ( 1 ): 81 - 89 . DOI: 10.4103/ijc.IJC_949_20 http://dx.doi.org/10.4103/ijc.IJC_949_20 .
BATEMAN R M , SHARPE M D , JAGGER J E , et al . 36th international symposium on intensive care and emergency medicine [J]. Crit Care , 2016 , 20 ( 2 ): 13 - 182 . DOI: 10.1186/s13054-016-1208-6 http://dx.doi.org/10.1186/s13054-016-1208-6 .
WEERINK M A S , STRUYS M M R F , HANNIVOORT L N , et al . Clinical pharmacokinetics and pharmacodynamics of dexmedetomidine [J]. Clin Pharmacokinet , 2017 , 56 ( 8 ): 893 - 913 . DOI: 10.1007/s40262-017-0507-7 http://dx.doi.org/10.1007/s40262-017-0507-7 .
Shehabi Y , Bellomo R , Kadiman S , et al . Sedation intensity in the first 48 hours of mechanical ventilation and 180-day mortality: a multinational prospective longitudinal cohort study [J]. Crit Care Med , 2018 , 46 ( 6 ): 850 - 859 . DOI: 10.1097/CCM.0000000000003071 http://dx.doi.org/10.1097/CCM.0000000000003071 .
HUGHES C G , MAILLOUX P T , DEVLIN J W , et al . Dexmedetomidine or propofol for sedation in mechanically ventilated adults with sepsis [J]. N Engl J Med , 2021 , 384 ( 15 ): 1424 - 1436 . DOI: 10.1056/NEJMoa2024922 http://dx.doi.org/10.1056/NEJMoa2024922 .
BURRY L , HUTTON B , WILLIAMSON D R , et al . Pharmacological interventions for the treatment of delirium in critically ill adults [J]. Cochrane Database Syst Rev , 2019 , 9 ( 9 ): CD011749 . DOI: 10.1002/14651858.CD011749. pub2 http://dx.doi.org/10.1002/14651858.CD011749.pub2 .
POLLARD T J , JOHNSON A E W , RAFFA J D , et al . The eICU Collaborative Research Database, a freely available multi-center database for critical care research [J]. Sci Data , 2018 , 5 : 180178 . DOI: 10.1038/sdata.2018.178 http://dx.doi.org/10.1038/sdata.2018.178 .
FUNK M J , WESTREICH D , WIESEN C , et al . Doubly robust estimation of causal effects [J]. Am J Epidemiol , 2011 , 173 ( 7 ): 761 - 767 . DOI: 10.1093/aje/kwq439 http://dx.doi.org/10.1093/aje/kwq439 .
0
Views
4
下载量
0
CSCD
Publicity Resources
Related Articles
Related Author
Related Institution
京公网安备11010802024621
